Giorgio Giannattasio M.D.

Giorgio Giannattasio is currently the Vice President, Head of Medical Affairs for Immunology and Rare Diseases, specifically Hereditary Angioedema, at Pharvaris. Prior to this role, Giannattasio held positions at Alexion Pharmaceuticals, Takeda, and Biogen, where Giorgio specialized in global medical affairs for various rare diseases and neurological conditions. Giorgio has a strong academic background with a PhD in Clinical Pathophysiology and Experimental Medicine from the University of Naples Federico II, where Giorgio also completed their MD residency in Clinical Immunology and Allergy. Additionally, Giorgio has experience as a Post-Doctoral Research Fellow at Harvard Medical School and Brigham and Women's Hospital.